Swedish Orphan Biovitrum AB (SWOBY)
23.28
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Swedish Orphan Biovitrum Debt to Equity Ratio : 0.4721 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.4721 |
| December 31, 2025 | 0.3048 |
| September 30, 2025 | 0.3777 |
| June 30, 2025 | 0.328 |
| March 31, 2025 | 0.3592 |
| December 31, 2024 | 0.4154 |
| September 30, 2024 | 0.4817 |
| June 30, 2024 | 0.4705 |
| March 31, 2024 | 0.5356 |
| December 31, 2023 | 0.6049 |
| September 30, 2023 | 0.6118 |
| June 30, 2023 | 0.9932 |
| March 31, 2023 | 0.3318 |
| December 31, 2022 | 0.3431 |
| September 30, 2022 | 0.4063 |
| June 30, 2022 | 0.405 |
| March 31, 2022 | 0.4114 |
| December 31, 2021 | 0.47 |
| September 30, 2021 | 0.5389 |
| June 30, 2021 | 0.5582 |
| March 31, 2021 | 0.6571 |
| December 31, 2020 | 0.7211 |
| September 30, 2020 | 0.7088 |
| June 30, 2020 | 0.6708 |
| March 31, 2020 | 0.828 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.9781 |
| September 30, 2019 | 0.5782 |
| June 30, 2019 | 0.3989 |
| March 31, 2019 | 0.4427 |
| December 31, 2018 | 0.0004 |
| September 30, 2018 | 0.0006 |
| June 30, 2018 | 0.0009 |
| March 31, 2018 | 0.0008 |
| December 31, 2017 | 0.0018 |
| September 30, 2017 | 0.0795 |
| June 30, 2017 | 0.0845 |
| March 31, 2017 | 0.0899 |
| December 31, 2016 | 0.0936 |
| September 30, 2016 | 0.0937 |
| June 30, 2016 | 0.0958 |
| March 31, 2016 | 0.1601 |
| December 31, 2015 | 0.1738 |
| September 30, 2015 | 0.1772 |
| June 30, 2015 | 0.1757 |
| March 31, 2015 | 0.1763 |
| December 31, 2014 | 0.1808 |
| September 30, 2014 | 0.1803 |
| June 30, 2014 | 0.1825 |
| March 31, 2014 | 0.1791 |
| December 31, 2013 | 0.1658 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Hansa Biopharma AB | -4.150 |
| BioArctic AB | 0.0185 |
| Diamyd Medical AB | 0.2527 |
| BONESUPPORT HOLDING AB | 0.015 |
| BioInvent International AB | 0.0142 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 8.530B |
| Total Liabilities (Quarterly) | 4.291B |
| Shareholders Equity (Quarterly) | 4.238B |
| Current Ratio | 0.7048 |
| Net Debt Paydown Yield | -0.72% |